Fenchlonine

Research use only, not for human use.

4-Chloro-DL-phenylalanine is a pharmaceutical intermediate.

4-Chloro-DL-phenylalanine is a pharmaceutical intermediate.

——

Fenclonine (intraperitoneal injection; 100 mg/kg; once daily; 3 d) treatment can inhibit Morphine-induced anti-nociceptive activity.Fenclonine (intraperitoneal injection; 300 mg/kg; once daily; 3 d) pretreatment completely abolishes the effects of a 50mg/kg dose of Paracetamol. Animal Model:Wistar albino rats of either sex and weighing between 80 and 100 g Dosage:100 mg/kg Administration:Intraperitoneal injection; 100 mg/kg; once daily; 3 days Result:Inhibited the antinociceptive activity of Morphine by 41.5%.Animal Model:Male Swiss mice (22–25 g)Dosage:300 mg/kg Administration:Intraperitoneal injection; 300 mg/kg; once daily; 3 days Result:Inhibited the effects of Paracetamol in depression-like and compulsion-like behavior.

PCPA

Others

Other Targets

Hydroxylases

Other Indications

——

7424-00-2

199.63

C9H10CINO2

>98% (HPLC)

Water: 10 mM

C(C(=O)O)(Cc1ccc(cc1)Cl)N

Alanine, 3-(4-chlorophenyl)-, DL-

(-20℃)

With Ice Pack

≥ 2 years